Literature DB >> 24393578

Hereditary hemochromatosis, iron, hepcidin, and coronary heart disease.

Luca Mascitelli1, Mark R Goldstein2.   

Abstract

Mounting evidence suggests that a state of sustained iron depletion may exert a primary protective action against coronary heart disease. A persistent criticism of the iron hypothesis has been that atherosclerosis may not be a prominent feature of hereditary hemochromatosis. The essence of this criticism is that iron cannot be a significant factor in atherogenesis in those unaffected by inherited iron overload unless an increase in atherosclerosis is observed in hereditary hemochromatosis. However, the emerging details of the physiology of hepcidin, the key hormone in iron recycling, suggest a resolution of the apparent paradox of an important role for iron in atherogenesis in the possible absence of increased plaque burden in most types of hereditary hemochromatosis.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24393578     DOI: 10.1016/j.mehy.2013.12.013

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  6 in total

1.  The Role of Iron in Atherosclerosis in Apolipoprotein E Deficient Mice.

Authors:  Juan Ma; Hui-Min Ma; Meng-Qi Shen; Yuan Yuan Wang; Yu-Xin Bao; Yong Liu; Ya Ke; Zhong-Ming Qian
Journal:  Front Cardiovasc Med       Date:  2022-05-20

Review 2.  Balance of cardiac and systemic hepcidin and its role in heart physiology and pathology.

Authors:  Driton Vela
Journal:  Lab Invest       Date:  2017-10-23       Impact factor: 5.662

3.  Hepcidin promotes osteogenic differentiation through the bone morphogenetic protein 2/small mothers against decapentaplegic and mitogen-activated protein kinase/P38 signaling pathways in mesenchymal stem cells.

Authors:  Huading Lu; Liyi Lian; Dehai Shi; Huiqing Zhao; Yuhu Dai
Journal:  Mol Med Rep       Date:  2014-10-24       Impact factor: 2.952

Review 4.  Ferroptosis: A Potential Target in Cardiovascular Disease.

Authors:  Yanlong Leng; Xing Luo; Jiaying Yu; Haibo Jia; Bo Yu
Journal:  Front Cell Dev Biol       Date:  2022-01-20

5.  Hepcidin-Induced Iron Deficiency Is Related to Transient Anemia and Hypoferremia in Kawasaki Disease Patients.

Authors:  Ying-Hsien Huang; Ho-Chang Kuo; Fu-Chen Huang; Hong-Ren Yu; Kai-Sheng Hsieh; Ya-Ling Yang; Jiunn-Ming Sheen; Sung-Chou Li; Hsing-Chun Kuo
Journal:  Int J Mol Sci       Date:  2016-05-12       Impact factor: 5.923

6.  Correlation of HAMP gene polymorphisms and expression with the susceptibility and length of hospital stays in Taiwanese children with Kawasaki disease.

Authors:  Ying-Hsien Huang; Kuender D Yang; Yu-Wen Hsu; Hsing-Fang Lu; Henry Sung-Ching Wong; Hong-Ren Yu; Hsing-Chun Kuo; Fu-Chen Huang; Mao-Hung Lo; Kai-Sheng Hsieh; Su-Fen Chen; Wei-Chiao Chang; Ho-Chang Kuo
Journal:  Oncotarget       Date:  2017-05-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.